NCT00939185已完成不适用
Compliance And Safety Study In Children With Upper And Lower Respiratory Tract Infections
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 400
- 主要终点
- Number of Patients With Adverse Events (AEs)
研究概览
简要总结
The objective of this study was to obtain data on the safety, tolerability and compliance with Zithromax in children with bacterial infections of the upper and lower respiratory tract.
详细描述
Patients were recruited from the outpatient departments of the participating sites/hospitals/clinics.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 1 Year 至 14 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with respiratory tract infections that received azithromycin according to the approved SPC as this was a non-interventional study.
排除标准
- •According to the approved Summary of Product Characteristics (SPC) for Azithromycin as this was a non interventional study.
研究组 & 干预措施
Azithromycin group
干预措施: Azithromycin (Drug)
结局指标
主要结局
Number of Patients With Adverse Events (AEs)
时间窗: 3 to 7 days after receiving treatment
All observed or volunteered AEs regardless of suspected causal relationship to the investigational product(s) were reported.
次要结局
- Number of Subjects Who Withdrew From the Study(3 to 7 days after receiving treatment)
- Compliance(3 to 7 days after receiving treatment)
- Time Reported for a Patient Being Consulted and Diagnosed From the Moment He/She Entered the Hospital(Day 1)
研究者
相似试验
已完成
不适用
An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin®Venous ThromboembolismNCT01046903Pfizer503
已完成
3 期
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection FractionChronic Heart Failure With Reduced Ejection FractionNCT02226120Novartis Pharmaceuticals1,980
已完成
3 期
Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment StudiesObstetric Labour, PrematureNCT02292784GlaxoSmithKline98
已完成
1 期
Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid TumorsNCT04047862BeiGene446
已完成
1 期
A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme PatientsGlioblastoma MultiformeNCT01588769CytoVac A/S23